Ebru Biricik
Adana, In the USA Or Canada, Please Select..., 01380, Turkey (Türkiye)
NCT Number: NCT03015350
16 patients with American Society of AnesthesioIogy (ASA) physical status I-III will recruited to this study. Patients will divided to the 2 groups. %1.5 Sevoflurane will apply in Group S and %6 Desflurane will apply in Group D. Each groups will divide 2 subgroups. Two lung ventilation will be performed to Group Sa and Group Da, one lung ventilation will be performed to Group Sb and Group Db. At the time point 40.minutes first blood sample will given from patients. Blood sample will be taken at intervals of 10 minutes from groups of two lung ventilation. In groups of one lung ventilation, blood samples will be taken at the time interval of 10 minutes after one lung ventilation started. All blood samples will be assess in Gas Chromatography.
Looking for future studies?
Notify Me25 year–65 year
All sexes
Observational
Adana, In the USA Or Canada, Please Select..., 01380, Turkey (Türkiye)
Investigator aimed to assess blood level of sevoflurane and desflurane during two lung ventilation and one lung ventilation. The investigators will use Gas Chromatography for define drugs levels. 16 patients with ASA I-III patients who undergo thoracotomy and abdominal surgery will be recruited to this study. Patients will divided in to the 2 groups. %1.5 Sevoflurane will apply in Group S and %6 Desflurane will apply in Group D during anesthesia maintenance. Each groups will divide 2 subgroups which are one lung ventilation groups and two lung ventilation groups. Two lung ventilation will be performed to Group Sa and Group Da, one lung ventilation will be performed to Group Sb and Group Db. Sequential blood samples will be taken from both arterial and central venous canula at the same time point. First blood samples will be taken at 40. minutes of anesthesia. Sequential samples will be taken at interval of 10 minutes during two lung ventilation. In one lung ventilation second blood samples will be taken at the 10. minutes of one lung ventilation. After than at the interval of 10 minutes, collection of blood samples both arterial and central venous will be continue.
All collection will assess with gas chromatography.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
ASA I-II patients
Exclusion criteria
Measurement of blood desflurane level during one lung ventilation
Other names: Blood sevoflurane level
Measurement of blood desflurane level during one lung ventilation
Other names: Blood desflurane level
Time frame: from 40th minute to the end of the operation
Data collections will be ensured from arterial and venous blood sample and than samples will be assessed with gas chromatography and blood sevoflurane and desflurane level will be measured. Blood samples will take every 10 minutes. Only blood levels of sevoflurane and desflurane will be assessed.
Time frame: from 40th minute to the end of the one lung ventilation
During one lung ventilation, p(a-A)O2 will be assessed with arterial blood analyses
Cukurova University
Other
Blood Levels of Sevoflurane and Desflurane During One Lung Ventilation
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03553446
Anesthetics, Inhalation, Brain Damage, Chronic
Daegu, South Korea
View Trial DetailsNCT03795259
Anesthesia, General, Anesthetics, Inhalation
Istanbul, Please Select, Turkey (Türkiye)
View Trial DetailsNCT01285271
Anesthetics, Inhalation, Cardiovascular Diseases
Aachen, North Rhine-Westphalia, Germany
View Trial DetailsNCT05867472
Anesthetics, Inhalation, Intensive Care Units, Pediatric
Hamilton, Ontario, Canada
View Trial Details